Clinician Suspicion for Lyme Disease and Clinical Decision-Making in Children with Monoarthritis

Insights

Diagnosing Lyme arthritis in children is challenging. Clinician suspicion moderately predicts Lyme disease but doesn't fully distinguish it from septic arthritis, necessitating better diagnostic tools.

Area of Science:

  • Pediatric infectious diseases
  • Rheumatology
  • Emergency medicine

Background:

  • Lyme disease is a significant concern in endemic areas, often presenting as monoarthritis in children.
  • Distinguishing Lyme arthritis from septic arthritis is critical due to differing treatment and potential complications.

Purpose of the Study:

  • To evaluate the diagnostic accuracy of clinician suspicion for Lyme arthritis in children presenting with monoarthritis.
  • To assess the impact of clinician suspicion on clinical decision-making, including invasive procedures, antibiotic use, and hospitalization.

Main Methods:

  • A large, multi-center cohort study of 1,582 children evaluated for Lyme disease in emergency departments.
  • Analysis of diagnostic accuracy using the area under the receiver operating characteristics curve (AUC).
  • Comparison of treatment and disposition decisions based on clinician suspicion levels.

Main Results:

  • Lyme arthritis was diagnosed in 39% of children with monoarthritis; septic arthritis occurred in 2%.
  • Clinician suspicion showed moderate discriminative ability for Lyme disease (AUC: 0.75).
  • Higher clinician suspicion correlated with reduced parenteral antibiotics and hospitalization, but not invasive procedures.

Conclusions:

  • Clinician suspicion has moderate accuracy but is insufficient to reliably differentiate Lyme from septic arthritis in pediatric monoarthritis cases.
  • Current clinical judgment impacts treatment intensity but does not eliminate invasive procedures.
  • Development of improved diagnostic tools is crucial for accurate and timely management of pediatric monoarthritis in Lyme-endemic regions.

Related Concept Videos

Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...